[IMRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[IMRX] Immuneering Corporation
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -6.84%
YoY- -94.00%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 94 184 190 482 660 748 665 -72.96%
PBT -11,527 -12,897 -11,092 -8,534 -7,987 -6,230 -5,836 57.61%
Tax -52 -29 -307 -17 1 0 42 -
NP -11,527 -12,867 -10,784 -8,534 -7,988 -6,230 -5,836 57.61%
Tax Rate - - - - - - - -
Total Cost 11,622 13,051 10,974 9,016 8,648 6,978 6,501 47.45%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -12,208.67 -7,004.48 -5,688.22 -1,770.08 -1,210.18 -832.62 -877.48 481.27%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.44 -0.49 -0.42 -0.47 -0.33 -0.46 -0.43 1.54%
EPS Diluted -0.44 -0.49 -0.42 -0.47 -0.33 -0.46 -0.43 1.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.